Takasago, Japan

Narumi Kishimoto

This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignee: Kaneka Corporation. Active years: 2008-2019.


% Patents Active = 40.0

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Hyogo, JP (2008)
  • Takasago, JP (2010 - 2019)

Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Narumi Kishimoto: Innovator in Pharmaceutical Chemistry

Introduction

Narumi Kishimoto is a prominent inventor based in Takasago, Japan. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. Her work focuses on innovative methods for producing important chemical compounds used in drug development.

Latest Patents

Kishimoto's latest patents include a method for producing tri-carbobenzoxy-arginine. This process involves carbobenzoxylating arginine or its derivatives using carbobenzoxy chloride and a base in a water/organic solvent bilayer system. Another notable patent is for the production of a β-amino-α-hydroxy carboxamide derivative. This process is crucial for drug production, allowing for the stable industrial-scale production of high-purity derivatives through a series of reactions and crystallization steps.

Career Highlights

Narumi Kishimoto is currently employed at Kaneka Corporation, where she continues to advance her research and development efforts. Her innovative approaches have positioned her as a key figure in her field, contributing to the development of new pharmaceutical compounds.

Collaborations

Kishimoto collaborates with esteemed colleagues, including Toshihiro Takeda and Akira Nishiyama. These partnerships enhance her research capabilities and foster innovation within her projects.

Conclusion

Narumi Kishimoto's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. Her patents and collaborations reflect her commitment to advancing drug development processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…